OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
2.950
-1.170 (-28.40%)
At close: Jan 17, 2025, 4:00 PM
3.069
+0.119 (4.04%)
After-hours: Jan 17, 2025, 7:59 PM EST
OS Therapies Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for OS Therapies stock have an average target of 17.5, with a low estimate of 15 and a high estimate of 20. The average target predicts an increase of 493.22% from the current stock price of 2.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OS Therapies stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $8 → $15 | Strong Buy | Maintains | $8 → $15 | +408.47% | Jan 16, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +577.97% | Jan 15, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +171.19% | Nov 26, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +611.86% | Oct 3, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +611.86% | Sep 16, 2024 |
Financial Forecast
Revenue This Year
209.61K
Revenue Next Year
56.10M
from 209.61K
Increased by 26,663.99%
EPS This Year
-1.16
from -0.74
EPS Next Year
1.50
from -1.16
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 431,550 | 115.5M | 33.9M |
| Avg | 209,610 | 56.1M | 24.4M |
| Low | n/a | n/a | 18.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 55,002.3% | -39.6% |
| Avg | - | 26,664.0% | -56.5% |
| Low | - | - | -66.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.49 | 3.20 | 0.45 |
| Avg | -1.16 | 1.50 | 0.22 |
| Low | -1.76 | -0.11 | - |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | -69.9% |
| Avg | - | - | -85.4% |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.